GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+7.91%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$388M
AUM Growth
+$388M
(+15%)
Cap. Flow
+$40.8M
Cap. Flow
% of AUM
10.53%
Top 10 Holdings %
Top 10 Hldgs %
49.94%
Holding
61
New
17
Increased
14
Reduced
13
Closed
10
Top Buys
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$17.6M |
| 2 |
Invesco CurrencyShares Swiss Franc Trust
FXF
|
$12.3M |
| 3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$10.7M |
| 4 |
Travere Therapeutics
TVTX
|
$10.1M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$9.92M |
Top Sells
| 1 |
Mersana Therapeutics
MRSN
|
$10.7M |
| 2 |
Arrowhead Research
ARWR
|
$9.52M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$8.74M |
| 4 |
Exelixis
EXEL
|
$8.61M |
| 5 |
PTC Therapeutics
PTCT
|
$8.23M |
Sector Composition
| 1 | Healthcare | 82.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sarepta Therapeutics
SRPT
$1.78B
| $33.9M | 7.21% | 210,000 +35,000 | +20% | +$5.65M |
|
|
2
PTC Therapeutics
PTCT
$3.92B
| $23.5M | 5% | 500,000 -175,000 | -26% | -$8.23M |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $20.5M | 4.36% | 435,300 -64,700 | -13% | -$3.05M |
|
|
ECYT
4
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $19.5M | 4.15% | 1,100,000 +600,000 | +120% | +$10.7M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $18.4M | 3.91% | 883,823 -366,177 | -29% | -$7.63M |
|
|
TSRO
6
DELISTED
TESARO, Inc.
TSRO
| $17.6M | 3.73% | +450,000 | New | +$17.6M |
|
|
DRNA
7
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $16.8M | 3.57% | 1,100,000 +440,000 | +67% | +$6.71M |
|
8
Ascendis Pharma
ASND
$11.8B
| $15.9M | 3.39% | 225,000 +50,000 | +29% | +$3.54M |
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $15.3M | 3.26% | 175,000 -35,000 | -17% | -$3.06M |
|
|
10
Invesco CurrencyShares Swiss Franc Trust
FXF
$376M
| $12.3M | 2.61% | +128,700 | New | +$12.3M |
|
11
Assembly Biosciences
ASMB
$190M
| $12.1M | 2.57% | 325,000 +90,000 | +38% | +$3.34M |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $11M | 2.33% | 75,000 -30,000 | -29% | -$4.38M |
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $10.4M | 2.21% | 500,000 -35,000 | -7% | -$727K |
|
|
14
Travere Therapeutics
TVTX
$1.56B
| $10.1M | 2.14% | +350,000 | New | +$10.1M |
|
|
ZGNX
15
DELISTED
Zogenix, Inc.
ZGNX
| $9.92M | 2.11% | +200,000 | New | +$9.92M |
|
16
Rocket Pharmaceuticals
RCKT
$354M
| $9.85M | 2.09% | 400,000 +50,000 | +14% | +$1.23M |
|
|
OBSV
17
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $9.65M | 2.05% | 535,000 +135,000 | +34% | +$2.43M |
|
18
argenx
ARGX
$43.6B
| $9.48M | 2.02% | 125,000 -25,000 | -17% | -$1.9M |
|
19
Larimar Therapeutics
LRMR
$310M
| $8.77M | 1.86% | 750,000 +647,737 | +633% | +$7.57M |
|
|
PTLA
20
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.99M | 1.7% | +300,000 | New | +$7.99M |
|
|
TCDA
21
DELISTED
Tricida, Inc. Common Stock
TCDA
| $7.64M | 1.62% | 250,000 +63,981 | +34% | +$1.95M |
|
|
BHVN
22
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.51M | 1.6% | +200,000 | New | +$7.51M |
|
|
VRAY
23
DELISTED
ViewRay, Inc.
VRAY
| $7.02M | 1.49% | 750,000 -150,000 | -17% | -$1.4M |
|
|
KDMN
24
DELISTED
Kadmon Holdings, Inc.
KDMN
| $6.68M | 1.42% | 2,000,000 +100,000 | +5% | +$334K |
|
25
AnaptysBio
ANAB
$569M
| $5.99M | 1.27% | 60,000 +44,300 | +282% | +$4.42M |
|